Results 31 to 40 of about 449,138 (190)

Parkinson’s Disease: No Milk Today? [PDF]

open access: yesFrontiers in Neurology, 2014
Several prospective epidemiological studies on large cohorts have consistently reported an association between milk intake and a higher incidence of Parkinson's disease (PD). Pesticide contamination of milk and milk's urate-lowering effects have been put forward as risk factors to explain epidemiological data.
Andrea eKistner   +4 more
openaire   +4 more sources

Impaired perception of biological motion in Parkinson’s disease [PDF]

open access: yes, 2016
OBJECTIVE: We examined biological motion perception in Parkinson’s disease (PD). Biological motion perception is related to one’s own motor function and depends on the integrity of brain areas affected in PD, including posterior superior temporal sulcus.
Cronin-Golomb, Alice   +3 more
core   +1 more source

Structural MRI Correlates of Episodic Memory Processes in Parkinson's Disease Without Mild Cognitive Impairment. [PDF]

open access: yes, 2015
BackgroundChanges in episodic memory are common early in Parkinson's disease (PD) and may be a risk factor for future cognitive decline. Although medial temporal lobe (MTL) memory and frontostriatal (FS) executive systems are thought to play different ...
Filoteo, J Vincent   +3 more
core   +2 more sources

Morphological changes of glutamatergic synapses in animal models of Parkinson’s disease

open access: yesFrontiers in Neuroanatomy, 2015
The striatum and the subthalamic nucleus are the main entry doors for extrinsic inputs to reach the basal ganglia circuitry. The cerebral cortex, thalamus and brainstem are the key sources of glutamatergic inputs to these nuclei.
Rosa M Villalba   +6 more
doaj   +1 more source

Peripheral Inflammation Enhances Microglia Response and Nigral Dopaminergic Cell Death in an in vivo MPTP Model of Parkinson’s Disease [PDF]

open access: yes, 2018
The impact of systemic inflammation in nigral dopaminergic cell loss remains unclear. Here, we have investigated the role of peripheral inflammation induced by systemic lipopolysaccharide (LPS) administration in the MPTP-based model of Parkinson’s ...
Carrillo Jiménez, Alejandro   +7 more
core   +3 more sources

Additional file 2: of Responsiveness of the short-form health survey and the Parkinsonâ s disease questionnaire in patients with Parkinsonâ s disease

open access: yes, 2017
Internal responsiveness of HRQoL in the stable patient group. (DOCX 20 kb)
Tu, Xiao-Jing   +3 more
openaire   +1 more source

Physical therapy and deep brain stimulation in Parkinson’s Disease: Protocol for a pilot randomized controlled trial [PDF]

open access: yes, 2018
Background Subthalamic nucleus deep brain stimulation (STN-DBS) reduces tremor, muscle stiffness, and bradykinesia in people with Parkinson’s Disease (PD).
Duncan, Ryan P   +4 more
core   +2 more sources

Poorer Cognitive Performance in Patients with Essential Tremor-Parkinson’s Disease vs. Patients with Parkinson’s Disease [PDF]

open access: yesFrontiers in Neurology, 2015
Patients with essential tremor (ET) seem to be at increased risk of developing Parkinson's disease (PD). Surprisingly, little has been written about this clinical entity, ET-PD. Cognitive dysfunction is a well-known feature of PD, and can also be an issue in patients with ET.
Louis, Elan D.   +3 more
openaire   +3 more sources

Gait abnormalities and non-motor symptoms predict abnormal dopaminergic imaging in presumed drug-induced Parkinsonism

open access: yesnpj Parkinson's Disease, 2022
Drug-induced parkinsonism (DIP) can be clinically indistinguishable from degenerative parkinsonism, and bedside assessments are needed to differentiate between these conditions. We examined 34 U.S.
Whitley W. Aamodt   +6 more
doaj   +1 more source

Factors affecting mortality in late stage Parkinson’s Disease [PDF]

open access: yes, 2019
To determine the effect of dysphagia and hospital admissions on mortality in late stage Parkinson’s ...
Dempsey, S.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy